Labetalol Tillomed Laboratories

Labetalol Hydrochloride, the active ingredient in Labetalol Tillomed Laboratories, is a beta‑adrenergic blocker with alpha‑1 blocking activity presented as an oral formulation for oral use. It is employed to treat essential hypertension, hypertensive emergencies, and hypertension associated with pheochromocytoma in adult patients. GNH USA supplies Labetalol Tillomed Laboratories as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Labetalol is indicated for conditions affecting the cardiovascular system where blood pressure control is required. - Essential hypertension: lowers systolic and diastolic pressure to reduce cardiovascular risk. - Hypertensive emergencies: provides rapid blood pressure reduction to prevent end‑organ damage. - Hypertension associated with pheochromocytoma: controls catecholamine‑induced spikes in blood pressure.

Adverse reactions may vary in frequency and severity.

Common Side Effects: - Dizziness - Fatigue - Headache - Nausea - Flushing - Nasal congestion

Serious or Rare Side Effects: - Severe hypotension - Bronchospasm, especially in asthmatic patients - Hepatic dysfunction or jaundice - Cardiac conduction abnormalities (e.g., heart block) - Acute heart failure exacerbation - Allergic reactions such as rash or angioedema

Before initiating therapy, clinicians should consider several safety aspects. - Blood pressure monitoring: regularly assess to avoid excessive hypotension. - Asthma or chronic obstructive pulmonary disease: use with caution due to β2 blockade. - Hepatic impairment: dose adjustment may be required. - Abrupt discontinuation: taper gradually to prevent rebound hypertension. - Diabetes mellitus: monitor glucose as β‑blockade may mask hypoglycaemia symptoms. - Store at ambient temperature: keep below 25°C in original packaging, protect from moisture and direct sunlight.

Labetalol can interact with other medicines, influencing its efficacy and safety.

Major Interactions (Avoid): - Concomitant use with other antihypertensives (e.g., ACE inhibitors, diuretics) may cause profound hypotension. - Combined with other β‑blockers can lead to excessive β‑blockade and bradycardia. - Interaction with calcium channel blockers (especially verapamil or diltiazem) may increase risk of heart block.

Moderate Interactions (Monitor Closely): - Clonidine: may require dose adjustment to prevent severe blood pressure drops. - NSAIDs: can reduce antihypertensive effect of labetalol. - Antidiabetic agents: β‑blockade may mask hypoglycaemia signs, requiring glucose monitoring. - Antidepressants (e.g., tricyclics): may enhance cardiac conduction effects. - Anesthetic agents: may potentiate hypotensive response during surgery.